Literature DB >> 8698464

Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens.

I Guillouard1, T Garnier, S T Cole.   

Abstract

The NH2-terminal domain of the alpha-toxin of Clostridium perfringens is highly homologous to the complete phospholipase C from Bacillus cereus (PC-PLC), for which a high-resolution crystal structure is available. This structural information was used as the basis of a site-directed mutagenesis strategy in which critical amino acid residues of alpha-toxin involved in zinc binding, interaction with substrate, or catalysis were replaced. Biochemical studies with the corresponding toxin variants indicate that there is probably a single active site endowed with lecithinase, sphingomyelinase, and hemolytic activities. By using a highly purified variant in which the catalytic aspartate residue at position 56 was replaced by asparagine, it was shown that phospholipase activity was essential for lethality in vivo and for mediating platelet aggregation in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698464      PMCID: PMC174095          DOI: 10.1128/iai.64.7.2440-2444.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens.

Authors:  A K Basak; D I Stuart; T Nikura; D H Bishop; D C Kelly; A Fearn; R W Titball
Journal:  J Mol Biol       Date:  1994-12-16       Impact factor: 5.469

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: nucleotide sequence and genetic linkage.

Authors:  M S Gilmore; A L Cruz-Rodz; M Leimeister-Wächter; J Kreft; W Goebel
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

5.  Monoclonal antibodies against alpha toxin of Clostridium perfringens.

Authors:  H Sato; J Chiba; Y Sato
Journal:  FEMS Microbiol Lett       Date:  1989-05       Impact factor: 2.742

6.  Phospholipase C and haemolytic activities of Clostridium perfringens alpha-toxin cloned in Escherichia coli: sequence and homology with a Bacillus cereus phospholipase C.

Authors:  D Leslie; N Fairweather; D Pickard; G Dougan; M Kehoe
Journal:  Mol Microbiol       Date:  1989-03       Impact factor: 3.501

7.  Nonspecific phospholipase C of Listeria monocytogenes: activity on phospholipids in Triton X-100-mixed micelles and in biological membranes.

Authors:  H Goldfine; N C Johnston; C Knob
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

8.  A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism.

Authors:  Y Fujii; J Sakurai
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

10.  Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens.

Authors:  D L Stevens; B E Troyer; D T Merrick; J E Mitten; R D Olson
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

View more
  12 in total

1.  Clostridium sordellii phospholipase C: gene cloning and comparison of enzymatic and biological activities with those of Clostridium perfringens and Clostridium bifermentans phospholipase C.

Authors:  Tadahiro Karasawa; Xingmin Wang; Tsuneo Maegawa; Yoshio Michiwa; Hiroyuki Kita; Koichi Miwa; Shinichi Nakamura
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Construction and characterization of a lactose-inducible promoter system for controlled gene expression in Clostridium perfringens.

Authors:  Andrea H Hartman; Hualan Liu; Stephen B Melville
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

3.  Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells.

Authors:  J D Firth; E E Putnins; H Larjava; V J Uitto
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

4.  Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities.

Authors:  M Nagahama; T Nakayama; K Michiue; J Sakurai
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Differences in the carboxy-terminal (Putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes.

Authors:  M Jepson; A Howells; H L Bullifent; B Bolgiano; D Crane; J Miller; J Holley; P Jayasekera; R W Titball
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Highly conserved alpha-toxin sequences of avian isolates of Clostridium perfringens.

Authors:  Scott A Sheedy; Aaron B Ingham; Julian I Rood; Robert J Moore
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

7.  Modulation of enzymatic activity and biological function of Listeria monocytogenes broad-range phospholipase C by amino acid substitutions and by replacement with the Bacillus cereus ortholog.

Authors:  W R Zückert; H Marquis; H Goldfine
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 8.  Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.

Authors:  Marcos Roberto A Ferreira; Gustavo Marçal S G Moreira; Carlos Eduardo P da Cunha; Marcelo Mendonça; Felipe M Salvarani; Ângela N Moreira; Fabricio R Conceição
Journal:  Toxins (Basel)       Date:  2016-11-21       Impact factor: 4.546

9.  A Fast and Inexpensive Protocol for Empirical Verification of Neutralizing Epitopes in Microbial Toxins and Enzymes.

Authors:  Christine N Vuong; Wen-Ko Chou; Vivek A Kuttappan; Billy M Hargis; Lisa R Bielke; Luc R Berghman
Journal:  Front Vet Sci       Date:  2017-06-13

10.  Evaluation of a toxoid fusion protein vaccine produced in plants to protect poultry against necrotic enteritis.

Authors:  Joseph G L Hunter; Shyra Wilde; Amanda M Tafoya; Jamie Horsman; Miranda Yousif; Andrew G Diamos; Kenneth L Roland; Hugh S Mason
Journal:  PeerJ       Date:  2019-03-28       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.